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ABSTRACT
Objectives: To evaluate our case of robot-assisted ureter-
olysis (RU), describe our surgical technique, and review
the literature on minimally invasive ureterolysis.
Methods: One patient managed with robot-assisted ure-
terolysis for idiopathic retroperitoneal fibrosis was identi-
fied. The chart was analyzed for demographics, operative
parameters, and immediate postoperative outcome. The
surgical technique was assessed and modified. Lastly, a
review of the published literature on ureterolysis managed
with minimally invasive surgery was performed.
Results: One patient underwent robot-assisted ureteroly-
sis at our institution in 2 separate settings. Operative time
(OR) decreased from 279 minutes to 191 minutes. Esti-
mated blood loss (EBL) was less than 50mL. The patient
has been free of symptoms and both renal units are un-
obstructed. According to the published literature, 302 re-
nal units underwent successful laparoscopic ureterolysis
(LU), and 6 renal units underwent RU. There were 9 open
conversions (all in LU). Mean OR in LU was 248 minutes
for unilateral and 386 minutes for bilateral cases. In RU,
mean OR was 220 minutes for unilateral and 390 minutes
for bilateral cases. EBL averaged 200mL in LU and 30 mL
in RU.
Conclusions: Our data reveal that robot-assisted ureter-
olysis is safe and feasible. Published data demonstrate the
advantages of minimally invasive surgery.
Key Words: Ureterolysis, Laparoscopy, Retroperitoneal
fibrosis, Robot-assisted.
INTRODUCTION
Ureteral obstruction secondary to extrinsic compression re-
sults from both benign and malignant processes. Retroperi-
toneal fibrosis (RPF) and ureteral endometriosis (UE) are 2
uncommon conditions that cause ureteral obstruction.1–25
First described in 1905 by Albarran and then by Ormond
in 1948, RPF is a chronic inflammatory process character-
ized by deposition of dense fibrous tissue within the
retroperitoneum.26–28 Possible causes of RPF include med-
ications, infections, malignancy, inflammatory conditions,
trauma, prior surgeries, and radiation therapy. About two-
thirds of cases are considered idiopathic.10,25
Endometriosis, defined by the ectopic presence of endo-
metrium, is another entity that can cause ureteral obstruc-
tion. Ureteral endometriosis occurs in 1% of patients
with endometriosis and is classified as extrinsic or intrin-
sic. Symptoms are often nonspecific and can be associated
with silent loss of renal function.22
Treatment of both RPF and UE has classically been to relieve
urinary tract obstruction, preserve renal function, and mini-
mize the morbidity associated with surgery.17 Open ureter-
olysis is effective in relieving ureteral obstruction, but can be
associated with complications.28 Minimally invasive surgery
offers rapid convalescence, lowers the need for postopera-
tive analgesic use, the need for blood transfusions, and is
associated with quicker return of bowel function.10 In 1992,
Kavoussi performed the first laparoscopic ureterolysis (LU),
and since then the minimally invasive approach has been an
accepted surgical alternative.1 Moreover, with the advent of
robotics, and its advantages, surgeons are now leaning to-
ward its use in ureterolysis.
We report on our first patient who underwent robot-
assisted laparoscopic ureterolysis (RU), describe our tech-
nique, and review the published literature on ureterolysis
via the minimally invasive approach.
MATERIALS AND METHODS
Case History
In February 2009, one male patient (2 renal units) under-
went robot-assisted laparoscopic ureterolysis. He pre-
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CASE REPORTsented initially with complaints of bilateral flank pain and
was found on an ultrasound, CT scan, and a MAG-3 renal
scan to have bilateral ureteral obstruction secondary to
presumed idiopathic retroperitoneal fibrosis. He subse-
quently failed conservative management including ure-
teral stent placement and steroid therapy. He was initially
scheduled to undergo bilateral ureterolysis; however, sec-
ondary to a prolonged operative time, right ureterolysis
was performed first, followed by left ureterolysis 3 months
later. The right renal unit was operated on first because of
the predominant function of 80% on renal scan. Both renal
units were stented and percutaneously drained preoper-
atively. Demographic information, operative parameters
and short-term outcome were assessed. Operative tech-
nique is briefly described below.
Literature Review
A literature search of on-line databases including PubMed
and Ovid MEDLINE (1950 through July 2009) for studies
describing laparoscopic and robot-assisted laparoscopic
ureterolysis was then conducted. Only articles published
in English were included. Thirty studies were identified.
We excluded 2 initial studies to prevent possible overlap
of patients during the same time frame by the same au-
thors. Two additional studies excluded were a case report
complicated by a pneumothorax secondary to a congen-
ital defect, and a case report complicated by multiple
gynecologic procedures. Hence, 26 series of LU and RU
published between 1992 and 2008 were reviewed, com-
prising 319 renal units (mean patient age, 44 years). These
are summarized in Table 1.1–25 We then tabulated oper-
ative parameters and outcome success.
Operative Technique for Robot-Assisted
Laparoscopic Ureterolysis
First Renal Unit (Right Side)
The patient was placed in a high flank position after
endotracheal and nasogastric intubation. A Foley catheter
was placed, bony prominences were padded, and the
table was then slightly flexed. Pneumoperitoneum was
initiated with a Veress needle. A 12-mm trocar was placed
in the midline just superior to the umbilicus. Two 8-mm
robotic trocars were placed, 4 cm cephalad and caudad to
the initial site, in the midclavicular line. A 5-mm trocar was
placed 4cm cephalad to the initial site in the midline. The
two 8-mm and the 5-mm ports were placed under direct
visualization. The white line of Toldt was then incised,
and the peritoneal structures reflected medially after the
robot was docked. Gerota’s fascia was identified and used
to localize normal ureter proximally. The ureter was then
traced to the encased area and sharply dissected free with
round tip scissors. The assistant provided retraction with a
suction device. A biopsy of the fibrotic mass was sent for
frozen section. The remainder of the fibrotic mass was
sent for permanent evaluation. A portion of posterior
peritoneum was mobilized and placed to “peritonealize”
the ureter. A 10-mm Jackson-Pratt drain was placed and
the trocar sites closed. The ureteral stent was left in
place. The right percutaneous nephrostomy tube was
clamped postoperatively.
Second Renal Unit (Left Side)
The patient was positioned and prepped as previously
described. However, after the pneumoperitoneum was
established with the Veress needle, the 12-mm trocar was
placed 2 cm below the costal margin in the anterior
axillary line. The two 8-mm ports were placed in the same
position described above. The 5-mm assistant trocar was
placed superior to the umbilicus in the midline. The tro-
cars again were placed under direct visualization. The
white line of Toldt was incised and reflected medially. We
decided to change the approach due to our past experi-
ence, and approach the distal ureter in the pelvis first. The
ureter was mobilized superiorly to the encased portion
down to the level of the fibrotic mass. The ureter was
traced superior to the encased segment and mobilized
down to the level of the fibrotic mass. A biopsy of the
fibrotic mass was sent for frozen section. The ureter was
then dissected free using round tip scissors. All of the
remaining fibrotic mass was excised and sent for perma-
nent evaluation. Indigo carmine was given intravenously,
and no extravasation was visualized from the ureter. The
ureter was “peritonealized” as previously stated. Trocar
sites were closed, and the ureteral stent was removed
cystoscopically prior to endotracheal extubation. The per-
cutaneous nephrostomy tube was manually occluded at
surgical completion.
RESULTS
Case Report
Clinical Presentation
A single patient (2 renal units) age 68 years old at our
institution underwent successful robot-assisted ureteroly-
sis in 2 separate encounters. Both renal units were prest-
ented and had preoperative nephrostomy tubes in place.
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retroperitoneal fibrosis.
Radiographic Evaluation
The patient was diagnosed with hydronephrosis seen
on renal ultrasound secondary to a rise in the creatinine
level from baseline. Subsequently, a CT scan of the
abdomen and pelvis demonstrated external compres-
sion of both ureters with medial deviation and bilateral
hydronephrosis. A preoperative MAG 3 renal scan was
performed that documented bilateral obstruction [T1/
2  23 minutes (right), 60 minutes (left)]. The patient
was also noted to have differential function of 85%
versus 15%, respectively.
Operative Parameters
Operative time was 279 minutes in the first surgery and
decreased to 191 minutes in the second. EBL was 50 mL
and 20 mL, respectively. There were no intraoperative
complications. Average length of hospital stay was 1
day.
Table 1.
Laparoscopic and Robotic Ureterolysis
Ref Series Date Technique No.
of Pts
Etiology Mean
Age
Gender No. of
Renal Units
Side
1 Kavoussi 1992 Lap 1 IRF 15 F 1 R
2 Puppo 1994 Lap 1 RF 46 M 2 B
3 Matsuda 1994 Lap 2 IRF 60 1F/1M 2 
4 Elashry 1996 Lap 6 2 IRF, 2 RF, 2 OVS 36 F 7 2L/3R/1 B
5 Nezhat 1996 Lap 10 Endometriosis 35 F 11 9 Uni /1 B
6 Boeckmann 1996 Lap 1 IRF 66 F 2 B
7 Mattalaer 1996 Lap 5 IRF 58.4 4F/1M 5 3R/2 B
8 Castilho 2000 Lap 2 IRF, Riedel’s thyroiditis 54.5 F 4 B
9 DeMirci 2001 Lap 1 RF 41 M 1 R
10 Fugita 2002 Lap 13 9 IRF, 5 medication-induced RF 52 4F/9M 20 4L/2R/7B
11 Donnez 2002 Lap 16 Endometriosis  F 17 7R/8L/1 B
12 Watanabe 2004 Lap 1 Endometriosis 43 F 1 L
13 Castle 2005 Lap 1 Erdheim-Chester disease 60 M 2 B
14 Okumura 2005 Lap 3 IRF 71 M 5 1L/2 B
15 Fong 2006 Lap 3 IRF 52.7 1F/2M 4 1L/1R/1 B
16 Brown 2006 Lap 5 IRF 56.4 3F/2M 10 B
17 Ghezzi 2006 Lap 33 Endometriosis  F 37 29 uni/4 B
18 Antonelli 2006 Lap 6 Endometriosis 33.1 F 7 5 uni/1 B
19 Schneider 2006 Lap 2 Endometriosis 34.8 F 2 
20 Frenna 2007 Lap 54 Endometriosis 31 F 46 25L/18R/11B
21 Sato 2008 Lap 1 OVS 41 F 1 R
22 Mereu 2008 Lap 35 Endometriosis 32.7 F 58 
23 Simone 2008 Lap 6 IRF 47 M 10 2 uni/4 B
24 Srinivasan 2008 Lap 34 17 IRF, 17 malignancy-induced RF 52 16F/18M 49 
25 Stifelman 2008 Lap 5 IRF 48.6 3F/2M 9 1 R/4 B
Robot 5 IRF 53.2 5M 6 1R3L1B
Totals 252 95 fibrosis, 157 endometriosis/OVS 319 renal
units
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Follow-up in our study was 6 months. Ureteral stents were
removed one week postoperatively followed by nephros-
tomy tube removal the following week. Replacement was
not required. Postoperatively, a renal scan demonstrated
an unobstructive pattern (T 1/2 10 minutes) on the right
renal unit, and an improved T 1/2 time on the left. A
postoperative renal ultrasound showed resolution of bi-
lateral hydronephrosis. The patient has been free of symp-
toms, and both renal units remain unobstructed. Biopsy
results of the retroperitoneum were benign, with evidence
of dense fibrous tissue.
Literature Review
In the laparoscopic/robotic review, 252 cases (319 renal
units) of ureterolysis were initially identified. A total of 308
renal units underwent successful ureterolysis. There were
9 (3.5%) conversions (11 renal units) to open surgery, all
within the LU group. Among the 308 renal units, 302 were
pure LU and 6 were RU. All patients in the LU and RU
groups were either prestented or had intraoperative ure-
teral stents placed prior to ureterolysis. In addition, several
had nephrostomy tubes in place.
Clinical Presentation
In the LU group, mean patient age was 44 years (range, 15
to 66), and in the RU group it was 53 years (range, 48 to
58). Ureteral obstruction was secondary to RPF in 95
patients, and secondary to endometriosis in 153 patients.
Three patients were diagnosed with ovarian vein syn-
drome and one with Erdheim-Chester disease, a rare pro-
gressive, non-Langerhans cell histiocytosis. The left side
was more commonly involved than the right side (54% vs.
46%). Unilateral disease was more prevalent, while bilat-
eral disease was seen in 43 patients.
Operative Parameters
Table 2 summarizes intraoperative data including mean
operative time, EBL, and operative technique for LU and
RU. Mean OR in LU was 248 minutes for unilateral and 386
minutes for bilateral cases. In RU, mean OR was 220
minutes for unilateral and 390 minutes for bilateral cases.
EBL averaged 200 mL in LU and 30 mL in RU. There were
12 intraoperative complications in the LU group, including
various injuries to the ureter, renal pelvis, iliac vein re-
quiring open conversion, and subcutaneous emphysema.
No intraoperative complications occurred in the RU
group. Average hospital stay was 4 days for LU and 3 days
for RU.
Radiographic Evaluation
In both MIS groups, pre- and postoperative radiographic
evaluation was variable. Evaluation included one or a
combination of these modalities: renal ultrasound (40%),
IVP (30%), CT scan (20%), and diuretic renography (20%).
Clinical Outcomes
Mean follow-up for LU was 21 months and 5 months for
RU. Recurrence was demonstrated in 12% of patients (12%
in RPF and 12% in UE). Those with recurrence were
managed with indwelling ureteral stents, or balloon dila-
tation of the ureter in one patient.15,25
DISCUSSION
RPF and UE are 2 conditions that can lead to ureteral
obstruction.1–25 In RPF, the fibrotic mass encases and com-
presses the ureters leading to hydronephrosis. Only 30%
of cases have an identifiable cause, with the remaining
70% being idiopathic.10,25 Management first entails de-
compression of the obstructed system, followed by dis-
continuation of offending agents if known and if not
consideration for medical management with corticoste-
roid therapy. Ruling out potential malignancy is important
in the evaluation.24,29 Traditionally open ureterolysis with
deep tissue biopsy, and repositioning the ureters laterally,
“intraperitonealizing” them or performing an omental
wrap has been the gold standard in surgical manage-
ment.4,24 A recent multi-institutional survey of laparo-
scopic surgeons by Duchene et al30 demonstrated that
there is no uniform treatment algorithm for RPF and that
most institutions recommend an attempt at steroids fol-
lowed by laparoscopic ureterolysis.
Ureteral endometriosis is another rare process, most
commonly diagnosed in women of childbearing age,
which can result in ureteral obstruction. It is usually
unilateral and involves the lower one-third of the ure-
ter.22 As previously mentioned, there is an extrinsic and
intrinsic type and they can coexist. Management of UE
is controversial.11 Treatment modalities have included
medical therapy alone, such as with progestin or dana-
zol, or in combination with ureteral stent placement,
ureterolysis, segmental ureterectomy, and nephroure-
terectomy.11,22
With the advent and advantages offered by minimally
invasive surgery, ureterolysis is now performed using
laparoscopy with or without robot assistance. Frenna and
associates20 reported on the benefits of laparoscopy in
patients with UE including the magnified image, superior
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pelvis and retroperitoneal space as well as in the lower
urinary tract. Operative times are reasonable despite often
requiring additional procedures. Additional procedures
include hysterectomy, salpingo-oophorectomy, excision
of endometrioma, bowel resection, nephrectomy, ureter-
ectomy with ureteroureteroneostomy, ureteroneocysto-
tomy, boari flap, ileal ureter, and others.
Table 2.
Intraoperative Data
Ref Series OR Time (min) EBL Transfusion Conversion Intra-op Complications LOS (days)
Laparoscopic Ureterolysis
1 Kavoussi 330 0 0 6
2 Puppo 540 3
3 Matsuda 389 1 (ureteral injury)
4 Elashry 255 140 2 0 0 2.8
5 Nezhat 1.8
6 Boeckmann 1 (subcut emphysema,
re-operation)
7
7 Mattalaer 301
240 unil
300 B
8 Castilho 216.7 “minimal” 0 0 1 (renal pelvis lac
re-operation)
4.5
9 DeMirci 200 0 5
10 Fugita 294 243 4
192 unil 245 1 2 1 (Boari flap)
381 B 241
11 Donnez
12 Watanabe
13 Castle hospice
14 Okumura 350 0
15 Fong
16 Brown 259 80 0 0 1 4.2
17 Ghezzi 230
18 Antonelli
19 Schneider
20 Frenna 1 (ureteral injury)
21 Sato
22 Mereu 330 325 3 (ureteral injury)
23 Simone 80 unil, 200 B 75 unil, 150B 3.33
24 Srinivasan 304.25 300 1 6 (iliac vein injury) 3 3.4 (IRF); 3
25 Stifelman 110 unil, 509 B 50 unil, 362.5 B 1 (B reimplant) 3.2
Totals /
Avg
248 unil, 386 B 188 unil, 208 B 4 9 12 4
Robotic Ureterolysis
25 Stifelman 220.5 unil, 390 B 25 unil, 35 B 0 3
Current
Study
279 R, 191 L 35 unil 0 0 None 1
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Kavoussi et al1 in 1992, several reports have been pub-
lished that demonstrate the efficacy and safety of the
laparoscopic approach.1–25 In 2008, Srinivasan and col-
leagues24 published one of the largest series of ureteroly-
sis, comparing open and laparoscopic techniques with
respect to morbidity and treatment efficacy. In their study,
the authors did not find any specific diagnosis or preop-
erative variable that influenced conversion to open sur-
gery, or predicted poor postoperative outcomes following
laparoscopic surgery. Complication rates were compara-
ble in both groups at 8% and postoperative imaging dem-
onstrated resolution of obstruction in both patient groups,
94% LU and 97% open.
In 2006 Mufarrij and Stifelman31 performed the first robot-
assisted laparoscopic ureterolysis with laparoscopic
omental wrap. Two years later, they reported on their
initial series of 5 patients. Their 2 most recent surgeries
were performed entirely robotically. They reported on the
advantages offered by robotics, including working in
magnified 3-dimension and the better articulation of in-
struments in assisting with dissection and freeing the dis-
eased ureter circumferentially.25,32
We are only the second institution to publish on robot-
assisted laparoscopic ureterolysis. The primary surgeon
(KG) has strong robotic pelvic surgical experience, having
performed over 700 robot-assisted pelvic procedures in-
cluding radical cystectomy and prostatectomy. Utilizing
the robot outside the pelvis contributed to the initial pro-
longed operative time and demonstrated the typical learn-
ing experience. Modifications were made to our tech-
nique. This included an alteration in port placement as
well as our operative approach. Dissecting the ureter first
beginning in the pelvis, instead of in an antegrade fashion
led us to a much easier and efficient second experience.
Utilizing that foundation of robot-assisted surgery within
the pelvis assisted the surgeon to operate from a more
familiar region as expected for a pelvic surgeon to an area
less encountered. Our experience, however, may be dif-
ferent than that of nonpelvic surgeons whose comfort
level may be the opposite.
CONCLUSIONS
Our data reveal that robot-assisted laparoscopic ureterol-
ysis is feasible and can be performed safely. Published
data demonstrate the clinical advantages of minimally
invasive surgery. Close monitoring and long-term fol-
low-up are essential given risk of recurrence.
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